Descrizione del progetto
Promuovere l’eccellenza della ricerca immunologica in Portogallo
La missione del progetto ImmunoHUB, finanziato dall’UE, è creare una piattaforma di eccellenza nella ricerca e innovazione presso l’Istituto di biologia molecolare e cellulare (IBMC-i3S) in Portogallo. Presso tale struttura vengono condotte ricerche sul cancro, sulle malattie infettive, sull’autoimmunità e sui disturbi neurodegenerativi, con una particolare attenzione alla deregolazione della risposta immunitaria. Il progetto ImmunoHUB promuoverà il progresso della ricerca immunologica nell’IBMC-i3S, portando l’Istituto in prima linea nella ricerca biomedica di base e traslazionale; inoltre, fornirà conoscenze, promuoverà le migliori pratiche accademiche per formare la prossima generazione di immunologi e sensibilizzerà il pubblico nei confronti dell’immunologia. Il progetto è in linea con le attuali politiche scientifiche del Portogallo e con le priorità del SER, evidenziate nell’ambito del programma Orizzonte 2020.
Obiettivo
The mission of an ERA Chair in Immunology (ImmunoHUB) is to create a Platform of excellence in research and innovation at IBMC-i3S (Portugal). Cancer, infectious diseases, autoimmunity and neurodegenerative disorders are major problems affecting our society. These pathologies are studied at IBMC-i3S and result in in part from deregulated immune responses, which makes Immunology a core pillar in our institute. Moreover, the successful usage of immune checkpoint blockade therapies has revolutionized the treatment of cancer and highlights the importance of understanding how to harness the Immune system for future development of vaccines or therapeutics against these diseases. Despite the contributions of our research groups for the understanding of how immune responses are orchestrated in health and disease, the international visibility of IBMC-i3S as a research center of Excellence in Immunology remains modest.
The ImmunoHUB action will (1) project Immunology at IBMC-i3S towards the forefront of basic and translational biomedical research, (2) provide knowledge of fundamental and economical value, (3) promote the finest academic practices to train the next generation of Immunologists and (4) widen public awareness for the importance of Immunology. Taking advantage of our high-quality scientific, technological, administrative and governance structures, we have set a comprehensive work plan to facilitate the integration and sustainability of the ERA Chair team and the implementation of the ImmunoHUB project. Our proposal is aligned with the existing scientific policy in Portugal and with the Societal Challenges and the ERA priorities identified by the European Commission under the H2020 program. Together, these synergistic actions will play a pivotal role to equip Portugal with the cornerstone infrastructures and human resources of the highest level to reach scientific excellence in Biomedical Research across Europe.
Campo scientifico
- medical and health scienceshealth sciencesinfectious diseases
- medical and health sciencesbasic medicineimmunology
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
- medical and health sciencesclinical medicineoncology
- medical and health sciencesbasic medicinepathology
Programma(i)
- H2020-EU.4.c. - Establishing ‚ERA Chairs’ Main Programme
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-WIDESPREAD-2018-2020-6
Meccanismo di finanziamento
CSA - Coordination and support actionCoordinatore
4200 135 Porto
Portogallo